Summary
Updated Aug 30, 2026
Paul Rothman is Director of Merck & Co., Inc. (MRK). 3 SEC Form 4 filings on record, most recently on 2 June 2026.
Recent Transactions
1Every recent SEC Form 4 transaction Paul Rothman has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Paul Rothman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jennifer Zachary - $25.20M of MRK open-market activity in the last 12 months
- Richard R. Deluca - $11.29M of MRK open-market activity in the last 12 months
- Chirfi Guindo - $8.15M of MRK open-market activity in the last 12 months
- David Michael Williams - $8.13M of MRK open-market activity in the last 12 months
- Robert M. Davis - $5.60M of MRK open-market activity in the last 12 months
- Caroline Litchfield - $5.02M of MRK open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Paul Rothman?
Paul Rothman is a corporate insider, tracked as Director of Merck & Co., Inc. (MRK). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Paul Rothman submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Paul Rothman's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Paul Rothman and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
